MedPath

To Compare and evaluate the effect of Nonsurgical periodontal therapy on serum levels of DNA sensing inflammasomes Absent in Melanoma 2(AIM2) Interferon ? inducible protein(IFI16) Cytokine interleukin(IL18) in Stage III periodontitis with and without Type 2 Diabetes Mellitus

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/06/068456
Lead Sponsor
Ranjeet Deshmukh Dental College and Research Centre Digdoh Hills Hingna road Nagpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group I Periodontally healthy patients presence of good oral hygiene with no visual signs of gingival inflammation bleeding on probing(BOP) in less than equal to 1 probing depth(PPD) less than equal to 3 mm

Group II Stage III periodontitis with a minimum of 15 teeth having PPD and clinical attachment level of greater than equal to four mm.

Group III Stage III periodontitis with T2DM PPD and CAL greater than equal to four mm. HbAonec levels in between 6.5 to 8 percentage

Exclusion Criteria

1 Patients who have undergone any periodontal therapy in the past 6 months

2 Patients with systemic diseases other than diabetes

3History of any medication including antibiotic treatment within the previous 3 months or regular use of specific drugs known to affect periodontal tissues

4 Pregnant women and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath